Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | HTT | P42858 | 3/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | VCAM1 | P19320 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | CXCR5 | P32302 | 1/20 | 0.30 |
| ▸ | APLNR | P35414 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | CCR6 | P51684 | 1/20 | 0.30 |
| ▸ | GFER | P55789 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9936364 | 0.91 | ALDH1A1 (0.44) | ALDH1A1HTTGAAVCAM1LMNA | |
| SCHEMBL1979584 | 0.77 | ALDH1A1 (0.47) | ALDH1A1HTTGAAMAPK1PKM | |
| SCHEMBL15127637 | 0.77 | ALDH1A1 (0.47) | ALDH1A1HTTGAAMAPK1PKM | |
| SCHEMBL9935270 | 0.76 | ALDH1A1 (0.41) | ALDH1A1HTTLMNAMAPK1PKM | |
| SCHEMBL14366682 | 0.76 | ALDH1A1 (0.49) | ALDH1A1HTTGAAMAPK1PKM | |
| SCHEMBL3968512 | 0.75 | MAPT (0.52) | ALDH1A1HTTMAPK1POLBKMT2A | |
| SCHEMBL3968471 | 0.73 | ALDH1A1 (0.37) | ALDH1A1HTTGAAVCAM1LMNA | |
| SCHEMBL10346382 | 0.70 | ALDH1A1 (0.62) | ALDH1A1HTTGAALMNAMAPK1 | |
| SCHEMBL3969613 | 0.68 | KMT2A (0.43) | GAAPOLBKMT2AMEN1HSP90AA1 | |
| SCHEMBL15127628 | 0.68 | HTT (0.49) | ALDH1A1HTTGAAVCAM1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2509951-B1 | NOVEL CATIONIC AMINOPYRIDINES, DYE COMPOSITION COMPRISING A CATIONIC AMINOPYRIDINE, PROCESSES THEREFOR AND USES THEREOF | ORÉAL L (FR) | 2016-04-13 | — | — | EP | disclosed |
| US-9220671-B2 | Dye composition comprising at least four dye precursors including at least one oxidation base and at least one coupler | L'OREAL (FR) | 2015-12-29 | — | — | US | disclosed |
| US-8491669-B2 | Cationic 4-aminopyridine, dye composition comprising a cationic 4-aminopyridine, processes therefor and uses thereof | L'OREAL (FR) | 2013-07-23 | — | — | US | disclosed |
| US-20130048007-A1 | NOVEL CATIONIC 4- AMINOINDOLES, DYE COMPOSITION COMPRISING A CATIONIC 4-AMINOINDOLE, PROCESSES THEREFOR AND USES THEREOF | L'OREAL (FR) | 2013-02-28 | — | — | US | disclosed |
| EP-2509951-A1 | NOVEL CATIONIC AMINOPYRIDINES, DYE COMPOSITION COMPRISING A CATIONIC AMINOPYRIDINE, PROCESSES THEREFOR AND USES THEREOF | L'Oréal (FR) | 2012-10-17 | — | — | EP | disclosed |
| WO-2011069898-A1 | NOVEL CATIONIC AMINOPYRIDINES, DYE COMPOSITION COMPRISING A CATIONIC AMINOPYRIDINE, PROCESSES THEREFOR AND USES THEREOF | L'OREAL (FR) | 2011-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130048007-A1 | NOVEL CATIONIC 4- AMINOINDOLES, DYE COMPOSITION COMPRISING A CATIONIC 4-AMINOINDOLE, PROCESSES THEREFOR AND USES THEREOF | TPH1, ALDH7A1, FARS2 | ALDH1A1 166/4885HTT 1342/4885GAA 4385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.